Skip to main navigation Skip to search Skip to main content

Should Patients With Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation Have Ventilatory Support Reduced to the Lowest Tolerable Settings? Yes

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)1143-1146
Number of pages4
JournalCritical care medicine
Volume47
Issue number8
DOIs
StatePublished - Aug 1 2019

Funding

1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health and Science University, Portland, OR. 2Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada. 3Division of Respirology, Department of Medicine, University Health Network and Sinai Health System, Toronto, ON, Canada. 4Keenan Research Center, Li Ka Shing Knowledge Institute, St Michael’s Hospital, Toronto, ON, Canada. Dr. Zakhary disclosed off-label product use of extracorporeal membrane oxygenation for respiratory failure. Dr. Fan received funding from MC3 Cardiopulmonary and ALung Technologies, and he is supported by a New Investigator Award from the Canadian Institutes of Health Research. Dr. Slutsky received funding from Maquet Critical Care, Novalung, and Baxter.

Funders
MC3 Cardiopulmonary and ALung Technologies
Canadian Institutes of Health Research

    Keywords

    • acute respiratory distress syndrome
    • extracorporeal membrane oxygenation
    • mechanical ventilation

    ASJC Scopus subject areas

    • Critical Care and Intensive Care Medicine

    Cite this